GranuFlo NaturaLyte Recall Attorneys
The GranuFlo NaturaLyte recall attorneys at the prestigious firm of Kelley, Berhneim, and Dolinsky, L.L.C. are currently meeting with victims of dialysis drugs who may be entitled to substantial compensation for their damages in a lawsuit against the maker of these dangerous pharmaceutical products, Fresenius Medical Care (FMC). GranuFlo and NaturaLyte have been linked to hundreds of deaths, and evidence clearly shows that FMC knew these products were dangerous but failed to take appropriate action to protect the public. Because of the marked risk these products pose to patients, they were recalled in March 2012.
If you or a loved one has suffered a cardiac event after dialysis with GranuFlo or NaturaLyte, we encourage you to contact a lawyer as soon as possible. You may be legally entitled to compensation, and a lawyer from our firm can help you learn more about your rights in a free legal consultation. A premier personal injury law firm, we provide each of our clients with:
- One-on-one attention and aggressive representation from an experienced GranuFlo Attorney
- Free consultations at your convenience: we frequently make home and hospital visits
- Nationwide protection for victims of GranuFlo or NaturaLyte
- We don’t charge any fees unless your case is won
What is GranuFlo?
When a person has chronic kidney disease, kidney failure, or other issues related to renal function, dialysis is used to artificially filter his or her blood. The blood is pumped through a machine (dialyzer) and it is treated with a chemical that helps to remove impurities from the blood. Often, this chemical is GranuFlo or NaturaLyte. The blood is then pumped back into the patient’s body.
Today, there are more than 400,000 dialysis patients in treatment at more than 5,700 dialysis centers in the United States. FMC owns the majority of these dialysis centers, and their products are used in nearly all dialysis centers in the nation.
GranuFlo NaturaLyte Problems
GranuFlo and NaturaLyte are used in the vast majority of dialysis centers in the U.S. These products have been linked to heightened levels of bicarbonate in patients’ blood, which could lead to metabolic alkalosis and put them at risk for cardiovascular events such as:
- Low blood pressure
- Cardiac arrhythmia
- Cardiopulmonary arrest
- Sudden heart arrest
- Heart attack
In an FMC study conducted between January 1 and December 31, 2010, patients in FMC dialysis centers across the country were monitored. When the study ended, experts from the pharmaceutical company concluded that when dialysis patients have elevated levels of bicarbonate in their blood before dialysis, they are at a six times higher risk for cardiopulmonary arrest and sudden cardiac death.
GranuFlo NaturaLyte Recall
In response to study results and overwhelming reports of patient injury and death after dialysis with GranuFlo and NaturaLyte, FMC issued an internal memo in November 4, 2011. In this memo, it was made clear that the company was aware of the increased risk of cardiac problems and death linked to their products. This memo was only provided to FMC doctors and dialysis centers, but when a copy of the memo was leaked to the FDA the company the dangers linked to these products became so glaringly apparent that the company was ordered to issue a Class 1 recall of both products. This recall was issued on March 29, 2012.
Amongst recalls, Class 1 recalls are the most severe and are issued after the determination of a reasonable probability that the products in question can cause adverse health problems or death.
GranuFlo NaturaLyte Lawsuits
According to the FMC memo issued internally after the 2010 study conducted by the same company, FMC was aware of the significant risks of heart attacks and death associated with GranuFlo and NaturaLyte. This memo was only provided to FMC doctors and dialysis centers, so other kidney doctors and treatment centers were not aware of the substantial harm that could affect their patients. The knowledge of the dangers linked to GranuFlo and NaturaLyte was only released publicly in March 2012, after the internal memo was leaked to the FDA the previous November. At that time, FMC was ordered to share all information linked to risks associated with these problems, but even then they did not comply, sharing an ambiguous memo that did not feature the details and urgent tone of the original memo. This new memo also included only one of the ten medical references included in the older internal memo.
Based on these facts, our dangerous drug lawyers can prove that FMC was well aware of dangers associated with their products, but that they put thousands of innocent patients at risk by not sharing this information. Furthermore, FMC continued to aggressively market GranuFlo and NaturaLyte, clearly putting profit over patient safety. This gross negligence means that FMC is financially and legally responsible to compensate the many thousands of victims and families affected by their dangerous drugs.
In GranuFlo and NaturaLyte lawsuits, our attorneys can bring their many years of experience to bear and we vow to fight until each one of our clients is compensated justly for their damages, which may include pain and suffering, lost wages, and the cost of medical care.
Contact our GranuFlo NaturaLyte Attorneys
If you or a person you love has suffered injury or death after dialysis, you may be a victim of defective pharmaceuticals GranuFlo or NaturaLyte, made by Fresenius Medical Care. If this is the case, FMC owes you significant compensation under the law. If you are interested in filing a dangerous drug lawsuit in pursuit of the full compensation to which you are entitled, contact the dangerous drug lawyers at Kelley, Bernheim, and Dolinsky, L.L.C. With years of experience in pharmaceutical product liability litigation, our GranuFlo and NaturaLyte attorneys will fight until dialysis drug victims achieve justice. Contact us today to learn more about your potential right to compensation in a free legal consultation.